Tong Shen Selected Research

Triglycerides (Triacylglycerol)

1/2023	Adipocytes reprogram cancer cell metabolism by diverting glucose towards glycerol-3-phosphate thereby promoting metastasis.
1/2022	Lipidomic biomarkers: Potential mediators of associations between urinary bisphenol A exposure and colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tong Shen Research Topics

Disease

35	Neoplasms (Cancer) 12/2023 - 11/2007
14	Inflammation (Inflammations) 01/2023 - 01/2017
12	Colorectal Neoplasms (Colorectal Cancer) 10/2023 - 05/2015
8	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2015
8	Dermatitis 01/2020 - 10/2007
7	Wounds and Injuries (Trauma) 11/2020 - 12/2012
6	Colitis 01/2022 - 02/2018
6	Hypersensitivity (Allergy) 11/2020 - 09/2008
5	Obesity 01/2023 - 11/2018
4	Body Weight (Weight, Body) 01/2023 - 01/2017
3	Breast Neoplasms (Breast Cancer) 03/2024 - 11/2007
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/2023 - 01/2019
3	Carcinoma (Carcinomatosis) 01/2023 - 01/2019
3	Carcinogenesis 01/2023 - 05/2015
3	Pneumonia (Pneumonitis) 09/2022 - 08/2018
3	Pain (Aches) 01/2020 - 12/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 10/2019 - 11/2016
3	Necrosis 10/2019 - 08/2014
2	Vascular Remodeling 02/2024 - 01/2017
2	Ischemic Stroke 02/2024 - 01/2017
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 09/2008
2	Lung Neoplasms (Lung Cancer) 01/2023 - 06/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2023 - 03/2017
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2023 - 02/2015
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 01/2021
2	Insulin Resistance 01/2023 - 01/2023
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 07/2008
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 12/2013
2	Immune System Diseases (Immune Disorders) 10/2020 - 10/2016
2	Lung Injury 08/2018 - 05/2018
2	Pathologic Processes 08/2017 - 01/2017
2	Stroke (Strokes) 01/2017 - 01/2017
2	Edema (Dropsy) 09/2015 - 07/2010
2	Erythema 09/2015 - 07/2010
1	Hypertension (High Blood Pressure) 03/2024
1	Metabolic Diseases (Metabolic Disease) 01/2023
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023
1	Mesothelioma 01/2023

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 12/2023 - 11/2007
13	Trichloroethylene (Trichloroethene)IBA 11/2020 - 10/2007
9	CytokinesIBA 02/2023 - 09/2015
8	Biomarkers (Surrogate Marker)IBA 12/2023 - 02/2015
8	bisphenol AIBA 10/2023 - 10/2016
5	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2019
5	ErbB Receptors (EGF Receptor)IBA 01/2017 - 11/2007
4	Interleukin-17 (Interleukin 17)IBA 01/2023 - 01/2017
4	EnzymesIBA 01/2023 - 01/2016
4	Adenosine Triphosphate (ATP)IBA 01/2023 - 11/2007
4	CollagenIBA 09/2022 - 01/2018
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2022
3	MicroRNAs (MicroRNA)IBA 01/2023 - 08/2017
3	AzoxymethaneIBA 01/2021 - 05/2015
3	SolventsIBA 01/2020 - 11/2018
3	Suramin (Suramin Sodium)IBA 07/2012 - 09/2008
3	Tyrosine Kinase InhibitorsIBA 01/2010 - 11/2007
3	ATP-Binding Cassette Transporters (ABC Transporters)IBA 10/2009 - 11/2007
2	Carbon Nanotubes (Carbon Nanotube)IBA 02/2023 - 09/2022
2	Messenger RNA (mRNA)IBA 01/2023 - 08/2017
2	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2022
2	Glycerophospholipids (Phosphoglycerides)IBA 01/2023 - 01/2022
2	Imatinib Mesylate (Gleevec)FDA Link 01/2023 - 10/2009
2	NickelIBA 01/2023 - 06/2020
2	LipidsIBA 07/2022 - 10/2019
2	atezolizumabIBA 03/2022 - 11/2021
2	Protein Isoforms (Isoforms)IBA 01/2022 - 11/2017
2	ElectrolytesIBA 01/2022 - 11/2010
2	Dextrans (Dextran)FDA Link 01/2022 - 12/2021
2	ChitosanIBA 01/2021 - 11/2020
2	Caspase 3 (Caspase-3)IBA 01/2021 - 01/2017
2	Dextran SulfateIBA 01/2021 - 08/2017
2	HydrogelsIBA 11/2020 - 07/2019
2	sodium bisulfide (NaHS)IBA 06/2020 - 01/2019
2	Fluorouracil (Carac)FDA LinkGeneric 12/2019 - 09/2008
2	CholesterolIBA 01/2019 - 01/2019
2	Immunoglobulin G (IgG)IBA 11/2018 - 01/2017
2	Sirtuin 1IBA 01/2018 - 11/2017
2	Monoclonal AntibodiesIBA 03/2017 - 01/2017
2	Conditioned Culture MediaIBA 01/2017 - 01/2017
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2016 - 12/2013
2	MicellesIBA 01/2016 - 09/2015
2	Dinitrochlorobenzene (DNCB)IBA 09/2015 - 07/2010
2	Gefitinib (Iressa)FDA Link 02/2009 - 11/2007
2	Mitoxantrone (Novantrone)FDA LinkGeneric 02/2009 - 11/2007
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2009 - 11/2007
2	Irritants (Vesicants)IBA 10/2007 - 12/2005
1	Tumor Biomarkers (Tumor Markers)IBA 12/2023
1	Bortezomib (Velcade)FDA Link 06/2023
1	Aligeron (AS 2)IBA 01/2023
1	MethyltransferasesIBA 01/2023
1	AcyltransferasesIBA 01/2023
1	Competitive Endogenous RNAIBA 01/2023
1	thermozymocidin (myriocin)IBA 01/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023

Therapy/Procedure

16	Therapeutics 02/2024 - 11/2007
3	Drug Therapy (Chemotherapy) 12/2013 - 09/2008
2	Transplantation 12/2021 - 01/2020
2	Aftercare (After-Treatment) 01/2017 - 01/2014
1	Ambulatory Surgical Procedures (Outpatient Surgery) 03/2024
1	General Anesthesia 03/2024
1	Anesthesia 03/2024